Takeda Kicks Off Effort On Globulin, Other COVID-19 Therapies
But China Plasma Collections Challenging
Japan's largest pharma firm has joined the global fray to develop potential therapies for the spreading coronavirus outbreak, focusing initially on its plasma products expertise. But this approach has had some challenges in China.
